RK PHARMA INC
US H-1B Labor Condition Application activity for RK PHARMA INC. Filed 76 disclosures between FY2017 and FY2026 from worksites with a NY headquarters indicator.
H-1B outcome breakdown
Share of RK PHARMA INC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 98.7% |
| Withdrawn | 1.3% |
Top occupations sponsored
SOC codes filed most by RK PHARMA INC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 46 |
| 2 | 17-2112 | Industrial Engineers | 11 |
| 3 | 13-1161 | Market Research Analysts and Marketing Specialists | 3 |
| 4 | 15-1253 | Software Quality Assurance Analysts and Testers | 2 |
| 5 | 17-2141 | Mechanical Engineers | 2 |
| 6 | 19-1022 | Microbiologists | 2 |
| 7 | 15-1299 | Computer Occupations, All Other | 1 |
| 8 | 17-2031 | Bioengineers and Biomedical Engineers | 1 |
| 9 | 11-1021 | General and Operations Managers | 1 |
| 10 | 29-2011 | Medical and Clinical Laboratory Technologists | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2017 | 2 |
| FY2019 | 3 |
| FY2023 | 3 |
| FY2024 | 41 |
| FY2025 | 20 |
| FY2026 | 7 |
| Period | Value |
|---|---|
| FY2017 | 2 |
| FY2019 | 3 |
| FY2023 | 3 |
| FY2024 | 41 |
| FY2025 | 20 |
| FY2026 | 7 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.